Amygdala Neurosciences

About Amygdala Neurosciences

Amygdala Neurosciences is a biopharmaceutical company focused on the development and commercialization of first-in-class drug candidates for the treatment of addiction disorders. Amygdala was founded and is led by industry leaders and therapeutic experts who include: Executive Chairman Lou Lange, MD, PhD; Chief Science Officer Ivan Diamond, MD, PhD; President and Chief Executive Officer Peter Strumph; and Chief Financial Officer Adrienne MacMillan.
YEAR FOUNDED:
2015
LEADERSHIP:
Executive Chairman and Founder: Lou Lange, MD, PhD
President, CEO and Founder: Peter Strumph
Founder and CSO: Ivan Diamond, MD, PhD
Founder and CFO: Adrienne MacMillan
TECHNOLOGY:
Please click here for Amygdala Neurosciences' technology.